Advisory Team

The Advisory Team at Atrin Pharmaceuticals provides expert guidance and strategic insights to support the discovery and development of proprietary molecules targeting DNA Damage and Response (DDR) pathways. They leverage their extensive experience in biopharmaceuticals to help steer research, clinical trials, and regulatory strategies, ensuring the company effectively addresses cancer treatment challenges associated with synthetic lethality and deregulated DNA Damage Response.